Analysts' updated eps estimates for Monday, March 27th:

StockNews.com assumed coverage on shares of Almaden Minerals (NYSE:AAU). The firm issued a sell rating on the stock.

StockNews.com assumed coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS). The firm issued a sell rating on the stock.

StockNews.com initiated coverage on shares of Ashford (NYSE:AINC). StockNews.com issued a buy rating on the stock.

StockNews.com initiated coverage on shares of Air Industries Group (NYSE:AIRI). They issued a hold rating on the stock.

StockNews.com initiated coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE). The firm issued a sell rating on the stock.

StockNews.com initiated coverage on shares of American Shared Hospital Services (NYSE:AMS). The firm issued a hold rating on the stock.

StockNews.com assumed coverage on shares of Argo Group International (NASDAQ:ARGO). StockNews.com issued a hold rating on the stock.

Autolus Therapeutics (NASDAQ:AUTL) had its overweight rating reaffirmed by analysts at Wells Fargo & Company. The firm currently has a $8.00 target price on the stock.

Fate Therapeutics (NASDAQ:FATE) had its equal weight rating reaffirmed by analysts at Wells Fargo & Company. They currently have a $6.00 target price on the stock.

Gracell Biotechnologies (NASDAQ:GRCL) had its overweight rating reaffirmed by analysts at Wells Fargo & Company. Wells Fargo & Company currently has a $7.00 price target on the stock.

Iovance Biotherapeutics (NASDAQ:IOVA) had its equal weight rating reiterated by analysts at Wells Fargo & Company. Wells Fargo & Company currently has a $11.00 target price on the stock.

Jounce Therapeutics (NASDAQ:JNCE) was downgraded by analysts at Piper Sandler from an overweight rating to a neutral rating.

Momentive Global (NASDAQ:MNTV) was downgraded by analysts at Truist Financial Co. from a buy rating to a hold rating.

Novartis (NYSE:NVS) was upgraded by analysts at Deutsche Bank Aktiengesellschaft from a sell rating to a hold rating.

Alaunos Therapeutics (NASDAQ:TCRT) had its overweight rating reissued by analysts at Wells Fargo & Company. They currently have a $3.00 target price on the stock.

Receive News & Ratings for Almaden Minerals Ltd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Almaden Minerals Ltd and related companies with MarketBeat.com's FREE daily email newsletter.